McLaughlin Melissa sold ALNY
April 2, 2026 · Form 4 insider transaction
McLaughlin Melissa sold 8 shares of Alnylam Pharmaceuticals, Inc. at $325.49 per share, a transaction worth $2.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
8
Price
$325.49
Total value
$2.6K
InsiderMcLaughlin Melissa
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2026
Filing dateApril 7, 2026
Shares owned after11,729
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units.